fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

CBD Treatment Case: Migraines

Published

on

If you’re not familiar with what it feels like to have a migraine, then consider yourself among the lucky. Migraines are far more common than most people realize. They impact a huge percentage of the world’s population.

A migraine is a severe, sustained headache that comes out of the blue. Light sensitivity and throbbing pain, as well as a sensitivity to sudden noises, characterize this terrible experience.

Unfortunately, even though this is a widely suffered condition, and even though the experience of an acute attack that characterizes this condition is considered to be so terrible, there is no one-size-fits-all remedy that migraine sufferers can turn to.

Some tools work for some people some of the time and to some extent. But nothing really does the job full stop.

Given all of that, we’re here today to bring the good news: CBD may be an important new knight in shining armor riding to the rescue for those suffering from migraines.

Understanding Migraines

To get a better feel for how CBD may offer new hope for those suffering from migraines, it’s important that we first understand more about migraines.

As noted above, those who suffer from migraines often say that the experience of an acute attack seems to come out of the blue. There is much debate in the scientific community about the true root cause of migraines. One of the most important facts to highlight this debate is the idea that the brain doesn’t have any pain sensors.

In other words, if someone were to pull off part of your cranium and look right down upon your exposed brain, they could poke it and prod it all they want and you would only feel a strange pressure, but no pain. It is thought that this is the only part of the body where that is true.

What we do understand is that the brain simply fails – in the case of a migraine – to locate the source of the pain. When you are suffering from a migraine, it feels as though the pain is coming from something that more or less represents the geometric center of your brain.

But the actual source of pain is likely very different – blood vessels, eyes, sinuses, upper neck, etc.

CBD and Migraines

Largely through anecdotal evidence, researchers have come to understand that CBD appears to have an extraordinarily powerful impact in improving the experience for those suffering from a migraine headache. But, at this point, we aren’t exactly sure why.

We do know that CBD has a strong ability to diminish sensitivity of pain, and also to re-balance the body’s internal endocannabinoid system when it is suffering from a deficiency.

It may be that, through some combination of these effects, CBD is able to generally impact the experience of a migraine for the better.

This should hardly be surprising given the role that the endocannabinoid system plays in all sorts of important regulatory functions in the body. This system is intimately tied into our experience of our moods, sleep patterns, digestive system, and sensitivity to pain.

Given that all of these factors are involved in the experience of a migraine headache, it should hardly come as shocking news that CBD – which helps to bring the endocannabinoid system out of deficiency and into balance – should show such promise as a therapeutic tool for those suffering from the terrible experience of a migraine.

Continue Reading
Advertisement

CBD CONDITIONS & TREATMENTS

WeedMD Inc (OTCMKTS:WDDMF) Rolls Out Its Color Cannabis Brand For Adults

Published

on

WeedMD Inc (OTCMKTS:WDDMF) has announced the launch of its latest brand called Color Cannabis as a premium brand that targets adult users that want high-grade cannabis products.

The new Color Cannabis premium brand features numerous strains of cannabis that are presented in multiple formats. However, they are also developed such that they have a high level of quality as per the expectations of the target consumers. WeedMD’s new brand will only be available to a few distributors and retailers in Canada.

WeedMD plans to have the Color Cannabis-branded products in select stores as well as online availability by Mid-June. The company created the brand with a strategic aim at the diverse preference and tastes of the modern-day cannabis consumer.

“We worked with globally-renowned agency Sid Lee to launch Color – our first adult-use brand,” stated Brett Moon, the Senior Vice President of sales and marketing at WeedMD.

The Color Cannabis brand to mainly focus on a premium user experience

Mr. Moon also noted that Color Cannabis is designed to inspire customers to embrace life and their cannabis experience in personal and unique ways. Aside from being available in the form of dried premium flower, the new WeedMD brand also hosts new product formats over the next few months. Some of those products include gel capsules, oils and pre-rolls and they will be made available with the creation of more consumption formats.

WeedMD CEO Keith Merker stated that Color Cannabis’ goal is to grasp the progressive character, individuality, and imagination of cannabis users. The CEO noted that the goal of the brand is not to tell clients what they will feel but rather to experience the products for themselves. Merker also noted that the Color Cannabis launch represents a key milestone for the company.

WeedMD expects to juggle between the new adult cannabis brand and its medical cannabis pursuits. The company expects to produce about 150,000 kilograms through its 5.2 million square feet production capacity by 2020. The firm also expects to have enough room to handle production for medical cannabis, as well as recreational adult use. It plans to achieve this through its indoor and outdoor growth facilities.

Continue Reading

CBD CONDITIONS & TREATMENTS

HempAmericana Inc. (OTCMKTS:HMPQ) CEO Issues Explains The Company’s Expansion

Published

on

HempAmericana Inc. (OTCMKTS:HMPQ) CEO has issued a letter to shareholders addressing the expansion of the company following string orders.

HempAmericana has begun bottling of full-spectrum CBD distillate

In the letter to shareholders, the CEO indicated that the company has begun establishing growth momentum in its CBD oil production as well as the distribution business. The CEO stated that the company has started bottling of 500 mg as well as 1000 mg full spectrum CBD distillate in its ultramodern CBD production and extraction facility in Augusta Maine.

He added that the company’s initial production is expected to be around 2,000 bottles per day which will be increased gradually to around 8,000 bottles a day to meet demand. Currently, the company has more than 50,000 full spectrum distillate bottles that are ready to be shipped with tens of thousands expected to follow.

HempAmericana is equally bottling a 250 mg potency that is suitable for the CBD-for-pets market. On the high end, the CEO indicated that the company is bottling 2500 mg and 5000 mg but he asserted that they have the potential of replicating any formula.

The CEO further went on to explain that production will be distributed under the company’s proprietary brand “Weed Got Oil.” He added that the company is also pursuing an opportunity in the white label market for the quality full-spectrum distillate CBD Oil. Currently, there are over 400 brands in the CBD market with the majority turning to high capacity producers such as HempAmericana to build product inventory.

Relationship with Eagle Hemp

The company recently announced a relationship with Florida based Eagle Hemp for an initial purchase order as well as the establishment of connections for more orders in the future. The company anticipates strong demand that includes compensation for more production of CBD oil as well as its bottling technology. The first order will bring the company significant revenue input at no associated costs to labeling, bottling, and shipping.

The company’s production facility and lab are currently operating well with two bottling machines in operation. The CEO said that once they distill the interest into purchase orders they will communicate to shareholders.

Continue Reading

CBD CONDITIONS & TREATMENTS

Medmen Enterprises Inc. (OTCMKTS:MMNFF) Expands Its Footprint In California With Acquisition Of One Love

Published

on

MedMen Enterprises Inc. (OTCMKTS:MMNFF) has announced the signing of a definitive agreement for the acquisition of 100% interest in MattnJeremy, Inc. One Love Beach Club.

Acquisition of One Love

The acquisition enhances the company’s California footprint by adding a premier location that is positioned strategically between its LAX and Santa Ana locations. The One Love Beach Club is currently on a run-rate of around $6 million in gross revenue and has an unaudited EBITDA margin of about 29%.

MedMen CEO Adam Bierman stated that they were delighted to have Long Beach on bard as part of the MedMen family as the company continues its growth in the world’s leading cannabis market.

One love was founded back in 2009 and it is located in Long Beach at 2767 E Broadway between Belmont Shore and Downtown some blocks from the beach. Long Beach is located 20 miles from Los Angeles and it is the third largest city in Southern California behind San Diego and Los Angeles with a population of almost half a million.

The city is a prime location that offers attractions, oceanfront hotels, events, recreation activities, shopping, nightly entertainment, restaurants as well as art and culture. According to the Long Beach Convention & Visitors Bureau in 2018 there were approximately 7.9 million visitors who visited the city to attend various events and attractions.

The One Love owner and operator Abrams Family indicated that it had been exciting to have served the Long Beach community for the last ten years adding that they were looking forward to MedMen to continue offering the community with premium cannabis.

Details of the transaction

According to the details of the transaction MedMen is expected to pay around $13 million of which $1 million will be in cash at closing of the deal and $2 million in deferred cash. The rest of the $10 million shall be fulfilled in Class B Subordinate Voting shares. Completion of the transactions depends on regulatory approval by state and local authorities as well as other routine closing conditions. The deal is expected to be closed within 45 days.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories